自然杀伤T细胞在表达肠道病毒样颗粒的腺病毒疫苗预防柯萨奇病毒A10感染中发挥重要作用
研究基于表达肠道病毒A71病毒样颗粒的腺病毒载体疫苗(AdVLP),在幼龄人清道夫受体B类成员2转基因小鼠中评估其对柯萨奇病毒A10(CVA10)的保护作用。AdVLP免疫显著降低肌肉、脊髓和脑的病毒载量并保护动物免于发病,而对照载体组大量CVA10累积导致严重疾病和死亡。过继转移AdVLP免疫脾淋巴细胞(而非去除iNKT细胞的淋巴细胞)使小鼠获得100%存活率,提示iNKT细胞介导的细胞免疫是AdVLP抗CVA10的关键保护机制。
要点
- AdVLP免疫显著降低CVA10攻击后小鼠肌肉、脊髓和脑的病毒载量并防止发病。
- AdVLP免疫血清抗体无中和活性但有病毒结合活性,被动免疫可有效保护。
- AdVLP免疫脾淋巴细胞过继转移实现100%存活,去除iNKT细胞后近乎全部死亡。
核心结论
- AdVLP通过诱导iNKT细胞和抗体介导的细胞反应,对EV-A71和CVA10提供多价保护,是抗CVA10感染的关键保护机制。
- 甲醛灭活CVA10(FI-CVA10)疫苗主要依赖中和抗体而非细胞免疫来预防CVA10感染。
研究设计与样本
- 研究在幼龄人清道夫受体B类成员2转基因(hSCARB2-Tg)小鼠中接种两剂AdVLP疫苗,随后进行CVA10攻击。
- 研究评估了FI-CVA10疫苗的效力,并进行了被动免疫研究,使用AdVLP免疫血清、FI-CVA10免疫血清以及AdVLP免疫脾淋巴细胞(含或不含iNKT细胞)过继转移。
主要发现
- AdVLP免疫显著降低CVA10攻击后小鼠肌肉、脊髓和脑的病毒载量,并保护动物免于发病;对照载体组这些组织大量CVA10累积,导致严重疾病和死亡。
- AdVLP免疫血清抗体虽无中和能力但具有病毒结合活性,被动免疫可有效保护Tg小鼠抵抗CVA10感染。
- FI-CVA10免疫血清可产生中和抗体,被动免疫研究显示其能有效预防CVA10感染。
- 接受AdVLP免疫脾淋巴细胞的Tg小鼠在CVA10攻击后存活率为100%,而接受去除iNKT细胞的淋巴细胞的小鼠几乎全部死亡。
- 接受FI-CVA10免疫脾淋巴细胞的Tg小鼠对CVA10攻击无抵抗力。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
We study a potent valent vaccine based on adenovector expressing enterovirus A71 (EV-A71) viral like particle (AdVLP) which elicits a multivalence against not only EV-A71 but also other coxsackieviruses such as A10. In young-aged human scavenger receptor class B, member 2 -transgenic ((hSCARB2-Tg) mice received two-dose of vaccine following challenge with CVA10, AdVLP immunization significantly reduced muscle, spinal cord, and brain's viral amounts and protected animal from disease occurrence. In contrast, massive CVA10 accumulated in these tissues that resulted in severe diseases and death in the control vector-received mice. Passive immunization of Tg mice with serum from AdVLP-immunized subjects, following challenge with CVA10, demonstrated that the antibodies in the serum though lacking neutralizing capabilities but exhibiting viral-binding activity effectively protected against CVA10 infection. We also evaluated the efficacy of the formalin-inactivated CVA10 (FI-CVA10) vaccine against CVA10 infection. Serum from FI-CVA10-immunized subjects was found to elicit neutralizing antibodies and was subsequently tested in a passive immunization study, demonstrating its effectiveness in preventing CVA10 infection. Notably, passive immunization of Tg mice with AdVLP-immunized splenic lymphocytes, compared to lymphocytes depleted of invariant natural killer T (iNKT) cells, revealed striking differences in outcomes following CVA10 challenge. Mice receiving iNKT-depleted lymphocytes experienced nearly complete mortality by challenge, whereas those receiving AdVLP-immunized lymphocytes achieved a 100 % survival rate. In contrast, Tg mice passively immunized with FI-CVA10-immunized splenic lymphocytes showed no resistance to CVA10 challenge. These findings indicate that FI-CVA10 relies primarily on neutralizing antibodies, rather than cellular immunity, for protection against CVA10 infection. Conversely, AdVLP demonstrates multivalent efficacy against both EV-A71 and CVA10 by inducing iNKT cells and antibody-mediated cellular responses, which together serve as key protective mechanisms against CVA10 infection.
引用
- Yu SL, Chung NH, Chen YC, et al. Natural killer T cells play a significant role in preventing Coxsackievirus A10 infection through an adeno-based vaccine expressing enterovirus-like particles. Vaccine. 2025. PMID: 41175651. doi:10.1016/j.vaccine.2025.127909
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。